136 related articles for article (PubMed ID: 4040706)
1. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
[TBL] [Abstract][Full Text] [Related]
2. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
Ngan HY; Wong LC; Ma HK
Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
[TBL] [Abstract][Full Text] [Related]
3. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
Liu LY
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
[TBL] [Abstract][Full Text] [Related]
4. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
Menczer J; Ben-Baruch G; Modan M; Brenner H
Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
[TBL] [Abstract][Full Text] [Related]
6. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
Hoskins WJ; Rubin SC; Dulaney E; Chapman D; Almadrones L; Saigo P; Markman M; Hakes T; Reichman B; Jones WB
Gynecol Oncol; 1989 Sep; 34(3):365-71. PubMed ID: 2548935
[TBL] [Abstract][Full Text] [Related]
7. Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer.
Miller DS; Spirtos NM; Ballon SC; Cox RS; Soriero OM; Teng NN
Cancer; 1992 Jan; 69(2):502-10. PubMed ID: 1728381
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant oral alkylating chemotherapy in patients with stage I epithelial ovarian cancer.
Gallion HH; van Nagell JR; Donaldson ES; Higgins RV; Powell DE; Kryscio RJ
Cancer; 1989 Mar; 63(6):1070-3. PubMed ID: 2917310
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential.
Yazigi R; Munoz AK; Sandstad J; Lifshitz S; Choi DJ
Eur J Gynaecol Oncol; 1991; 12(6):451-5. PubMed ID: 1809577
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
11. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
12. Advanced ovarian cancer: long-term results following chemotherapy and second-look laparotomy.
Davidson NG; Khanna S; Kirwan P; Bircumshaw D
Gynecol Oncol; 1990 Dec; 39(3):295-9. PubMed ID: 2258074
[TBL] [Abstract][Full Text] [Related]
13. Survival with intraperitoneal cisplatin in advanced ovarian cancer after second-look laparotomy.
de Gramont A; Demuynck B; Louvet C; Gonzalez-Canali G; Varette C; Pigné A; Marpeau L; Herbulot P; Lagadec B; Cady J
Am J Clin Oncol; 1992 Feb; 15(1):7-11. PubMed ID: 1550083
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
[TBL] [Abstract][Full Text] [Related]
15. Second-look laparotomy in ovarian carcinoma patients after 8 and after 12 courses of cisplatin-based chemotherapy.
Menczer J; Ben-Baruch G; Modan M; Brenner H
Gynecol Obstet Invest; 1989; 27(2):102-4. PubMed ID: 2731767
[TBL] [Abstract][Full Text] [Related]
16. The current therapeutic approaches to advanced ovarian cancer.
Nishimura H; Hamaguchi K; Miyahara K; Tazaki T; Tateno N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1691-6. PubMed ID: 2277209
[TBL] [Abstract][Full Text] [Related]
17. Second-look laparotomy and salvage therapy: a research modality only?
Potter ME; Hatch KD; Soong SJ; Partridge EE; Austin JM; Shingleton HM
Gynecol Oncol; 1992 Jan; 44(1):3-9. PubMed ID: 1303613
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.
Sutton GP; Stehman FB; Einhorn LH; Roth LM; Blessing JA; Ehrlich CE
J Clin Oncol; 1989 Feb; 7(2):223-9. PubMed ID: 2915238
[TBL] [Abstract][Full Text] [Related]
19. The role of second-look laparotomy in the management of patients with ovarian carcinoma.
Rome RM; Fortune DW
Aust N Z J Obstet Gynaecol; 1988 Nov; 28(4):318-23. PubMed ID: 3250451
[TBL] [Abstract][Full Text] [Related]
20. Primary chemotherapy and the role of second-look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary.
Pippitt CH; Cain JM; Hakes TB; Pierce VK; Lewis JL
Gynecol Oncol; 1988 Oct; 31(2):268-75. PubMed ID: 2458993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]